Cas:5378-35-8 3-(1,3,4-oxadiazol-2-yl)aniline manufacturer & supplier

We serve Chemical Name:3-(1,3,4-oxadiazol-2-yl)aniline CAS:5378-35-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(1,3,4-oxadiazol-2-yl)aniline

Chemical Name:3-(1,3,4-oxadiazol-2-yl)aniline
CAS.NO:5378-35-8
Synonyms:3-[1,3,4]oxadiazol-2-yl-aniline;2-(3-Amino-phenyl)-1.3.4-oxdiazol;3-(1,3,4-oxadiazol-2-yl)phenylamine
Molecular Formula:C8H7N3O
Molecular Weight:161.16100
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:64.94000
Exact Mass:161.05900
LogP:1.90000

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-[1,3,4]oxadiazol-2-yl-aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(1,3,4-oxadiazol-2-yl)phenylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3-Amino-phenyl)-1.3.4-oxdiazol Use and application,2-(3-Amino-phenyl)-1.3.4-oxdiazol technical grade,usp/ep/jp grade.


Related News: Not only will we be able to better support our enterprise partners and their teams, we’ll be helping individual members unlock their full potential and achieve peak performance.” 5-[4-(1,4-dioxa-8-aza-spiro[4.5]dec-8-yl)-phenyl]-1,2-dihydro-pyrazol-3-one manufacturers As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. 2-pentaoxidaneyl-13,24,34,43,53,63-hexaoxin-3-ol compound with hydrogen peroxide (1:1) suppliers The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance. N-[9-(N,N-dimethylethylenediamino)]-3,6-bis(3-pyrrolidinopropionamido)acridine vendor & factory.